Ex parte ADEWUYI et al. - Page 9



              Appeal No. 95-2227                                                                                        
              Application No. 08/048,964                                                                                

            (Fed. Cir. 1992).  On these circumstances, we are constrained to reach the conclusion that                  
            the examiner has failed to establish that it would have been obvious to those of ordinary skill             
            in the art at the time of the invention to periodically measure the C7 to C10 n-olefin and C7 to            
            C10 cyclic olefin content (Clm.18) or to periodically measure at least one of the butadiene                 
            and methane yields (Clm. 19), in a catalytic cracking process, with  the purpose of  controlling            
            the amount of zeolite catalyst present in the reaction mixture.  The examiner's rejections of the           
            claims are fatally defective since they do not properly account for and establish the                       
            obviousness of the subject matter as a whole.  Where the examiner fails to establish a prima                
            facie case, the rejection is improper and will be overturned.  In re Fine, 837 F.2d 1071, 1074,             
            5 USPQ2d 1596, 1598 (Fed. Cir.1988).                                                                        
                   The rejections of claims 18-20 is reversed.                                                          
                                                     SUMMARY:                                                           

                   The rejections of claims 1-17 as being unpatentable under 35 U.S.C. § 103 are                        
            affirmed.  The rejections of claims 18-20 as being unpatentable under 35 U.S.C. § 103 are                   
            reversed.                                                                                                   
                   We affirm-in-part.                                                                                   










                                                           9                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007